|
Pushkarmoola is beneficial for:
cardiovascular system
angina
dyspnea
Animal Research
In an experiment, rats were given Inula before and after
experimental myocardial infarction. Animals given Inula had
smaller increases in SGOT, LDH, CPK, CAMP, cortisol, pyruvate,
lactate, and glucose than those in an untreated control group.
1
Clinical Research
Inula was studied in combination with Guggul (Commiphora
mukul) using a 1:1 mixture. 200 patients with ischemic heart
disease were used in the trial. Approximately 80 percent experienced
dyspnea, and all 200 subjects had chest pain, with
positive indications of myocardial ischemia.
Guggul (Commiphora) is known for its lipid-lowering qualities.
It may partially explain the lowering of total cholesterol
by 39-percent in these patients. There was also a 51-percent
decrease in triglycerides and 32-percent decrease in total
blood lipids.
The other results were also equally remarkable. At the end
of the six-month study period, 26 percent of the subjects
had a complete restoration of normal ECG. Another 59 percent
showed improvement in the ECG. Twenty-five percent of the
subjects had no chest pain, and patients experiencing dyspnea
fell from 80 percent at the beginning of the study to 32 percent.
2
In another trial, the efficacy of Inula was compared to nitroglycerin
for the prevention of anginal symptoms. Nine subjects with
ischemic heart disease was used in the study. All patients
experienced chest pain and showed positive for myocardial
ischemia by their ECG ST-segment depression on exertion. The
Inula group received 3 grams root powder 90 minutes prior
to testing. The controls were given nitroglycerin. All nine
subjects had improvement in ST-segment depression on ECG.
However, the improvement was greater for those who were given
inula. 3
|
